# DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer

> **NCT00603460** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **University of Pennsylvania**

## Conditions studied

- Ovarian Cancer
- Primary Peritoneal Cancer

## Interventions

- **BIOLOGICAL:** DCVax-L and T Cells

## Key facts

- **NCT ID:** NCT00603460
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-03
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00603460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00603460, "DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00603460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*